Eden Research plc Appointment of Auditor (9772A)

TIDMEDEN

RNS Number : 9772A

Eden Research plc

28 September 2022

Eden Research Plc

("Eden" or "Company")

Change of Auditor

Eden Research plc (AIM: EDEN; OTCQB: EDNSF), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, today announces that, following a competitive and comprehensive tender process, PKF Littlejohn LLP ("PKF") has been appointed as the Company's auditor for the year ending 31 December 2022. The Company intends to put the appointment of PKF as auditor to a vote of shareholders at the Company's next Annual General Meeting.

Following the tender process and the decision to appoint PKF, KPMG UK LLP ("KPMG") has resigned. The Board wishes to take this opportunity to extend appreciation to KPMG for its services rendered to the Company.

As required by section 519 of the Companies Act 2006, KPMG has deposited a statement with the Company confirming that there are no circumstances in connection with its resignation as auditor that should be brought to the attention of the Company's shareholders and the reason for their resignation was as a result of its fees no longer being acceptable to the Company.

For further information, contact:

 
 Eden Research plc                             www.edenresearch.com 
  Sean Smith                                          01285 359 555 
  Alex Abrey 
 Cenkos Securities (NOMAD and broker) 
  Giles Balleny / Max Gould (Corporate 
  Finance) 
  Michael Johnson (Sales)                             020 7397 8900 
 Hawthorn Advisors                        eden@hawthornadvisors.com 
  Stephen Atkinson 
  Victoria Ainsworth

Notes to Editors:

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has two products currently on the market:

Based on plant-derived active ingredients, Mevalone (R) is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops. It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally.

Cedroz (TM) is a bio-nematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally. Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.

Eden's Sustaine (R) encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.

   For more information about Eden, please visit:   www.edenresearch.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

APPEAXNPALSAEEA

(END) Dow Jones Newswires

September 28, 2022 03:46 ET (07:46 GMT)

Eden Research (AQSE:EDEN.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024